# A Pharmacokinetic Study of TP-05 in Healthy Subjects

> **NCT05138796** · PHASE1 · COMPLETED · sponsor: **Tarsus Pharmaceuticals, Inc.** · enrollment: 67 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** TP-05 (lotilaner oral capsules)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05138796
- **Lead sponsor:** Tarsus Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-05-06
- **Primary completion:** 2022-03-25
- **Final completion:** 2022-07-25
- **Target enrollment:** 67 (ACTUAL)
- **Last updated:** 2022-08-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05138796

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05138796, "A Pharmacokinetic Study of TP-05 in Healthy Subjects". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05138796. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*